PDUFA IV: You Can't Always Get What You Want
This article was originally published in RPM Report
Executive Summary
Former Senate HELP Committee FDA counsel Steven Irizarry looks ahead at the reauthorization of PDUFA and what drug companies should expect in the latest round of negotiations.